Angiopoietins and Breast Cancer Prognosis
Author Information
Author(s): Rmali Khaled A, Watkins Gareth, Douglas-Jones Antonio, Mansel Robert E, Jiang Wen G
Primary Institution: Cardiff University School of Medicine
Hypothesis
The study aimed to examine the expression levels of Ang-1, Ang-2, Ang-3, and their receptor Tie-2 in ductal mammary carcinoma and assess their relevance to prognosis.
Conclusion
Angiopoietins have limited value in predicting the prognosis and clinical outcome in patients with mammary ductal carcinoma.
Supporting Evidence
- Ang-1, Ang-2, and Ang-3 were expressed in both normal and cancerous breast tissues.
- No significant differences were found in angiopoietin levels between different prognostic groups.
- Ang-3 levels were higher in cancer tissues compared to normal, but not significantly.
Takeaway
The study looked at certain proteins in breast cancer tissues to see if they could help predict how patients would do, but they didn't find any clear answers.
Methodology
The study used quantitative RT-PCR and immunohistochemistry to analyze the expression of angiopoietins in frozen breast cancer and adjacent normal tissues.
Limitations
The study was limited by its sample size, which may affect the reliability of the findings.
Participant Demographics
The study included 90 patients with ductal carcinoma and 32 adjacent non-cancerous tissues from the same patients.
Statistical Information
P-Value
p > 0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website